Immunogenetic Background of Chronic Lymphoproliferative Disorders in Romanian Patients-Case Control Study.

Maria TizuBogdan CalenicIon MarunteluAndreea Mirela CarageaAdriana TalangescuLarisa UrsuCorina RotarescuMariana SurugiuAlexandra Elena ConstantinescuIleana Constantinescu

Published in: Medical sciences (Basel, Switzerland) (2024)

Our study indicates that HLA-C*02:02 and HLA-C*12:02 are positively associated with chronic lymphoproliferative disorders for our Romanian patients while HLA-DRB1*11:01, HLA-DRB1*13:02, and HLA-B*35:02 alleles have a protective role against these diseases.

Keyphrases

end stage renal disease
ejection fraction
peritoneal dialysis
prognostic factors
epstein barr virus